Navigation Links
Nobel Laureate to Join Grove Instruments Board of Directors
Date:12/5/2011

WORCESTER, Mass., Dec. 5, 2011 /PRNewswire/ -- Grove Instruments, Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that Craig Mello, Ph.D. is joining the Board of Directors.  Dr. Mello is a Howard Hughes Medical Institute Investigator and the Blais University Chair of Molecular Medicine and Co-Director of the RNA Therapeutics Institute at the University of Massachusetts School of Medicine.  Dr. Mello's pioneering research on RNA inhibition (RNAi), in collaboration with Dr. Andrew Fire, has been recognized with numerous prestigious awards culminating with the 2006 Nobel Prize in Physiology or Medicine. "We are building a world class medical technology company and the addition of Dr. Mello to our Board is another step in our continuing quest for excellence at every level," said Arthur Combs, CEO of Grove.

Dr. Mello's renown in the scientific community is equaled only by his dedication to the care of people with diabetes.  His passion and commitment for diabetes care emanate from a deeply personal experience raising a child with type 1 diabetes.  "Experiencing the 24-hour-a-day every day nature of this disease, really makes you appreciate the tremendous potential benefit of Grove's technology," says Mello.  After 2 years as an Advisor to the Company Dr. Mello decided, "I wanted more involvement – an opportunity to make a bigger impact on the success of the Company and its technology."

"Having a man of science with Dr. Mello's credentials and gravitas is just fantastic for the Company," noted Dr. Paul Lock, career diabetologist and longest seated Board member.  Dr. Robert Peura, Grove Co-founder and father of two children with type 1 diabetes, said, "This is just terrific! I know how powerful it will be to have Craig join us – I know he truly understands the needs of children with diabetes, and how Grove can help."

"This
'/>"/>

SOURCE Grove Instruments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Elsevier Honors the 2011 Nobel Laureates
2. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
3. Live Coverage of 2011 Nobel Prize Announcements and Exclusive Content on Nobelprize.org
4. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
5. Thomson Reuters Predicts Nobel Laureates
6. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
7. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
8. Nobel Prize-Winning Discovery
9. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
10. Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
11. Laureates Electronic Submission Gateway Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
(Date:7/30/2014)... The Restore My Blood Sugar review recently published ... levels can now find an amazingly successful method of reducing ... created by D. Chao and Andrew Forester who claim that ... it comes to normalizing blood sugar levels. Chao actually is ... to the cure of diabetes that all patients should find ...
(Date:7/30/2014)... July 30, 2014 New changes are in ... plans to move to a new facility. The official date ... will be moving soon. , MedX Pharmacy will be moving ... Pearland, TX 77581. This is the old Wells Fargo building. ... and will include a drive thru for convenient drop-off and ...
(Date:7/30/2014)... Conducting Advanced Root Cause Analysis ... and Innovative Techniques to Improve the Quality of ... Sept. 17-18, 2014 – Raleigh, NC, http://www.fdanews.com/CAPAWorkshopRaleigh ... for 483 observations since 1997. , The FDA's ... CAPA program has never been more important. , ...
(Date:7/30/2014)... drug to treat malaria, is now widespread throughout ... ( P. falciparum ) parasites that cause the ... mutation in the parasites. However, a six-day course ... three-day coursehas proved highly effective in treating drug-resistant ... the New England Journal of Medicine . ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- It can happen in ... television, dresser or computer monitor and gets critically injured when ... a young child should look around their homes and imagine ... child. Imagining it is better than it becoming a reality," ... Physicians, said in a college news release. Between 2009 ...
Breaking Medicine News(10 mins):Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:MedX Pharmacy Relocates to New Facility 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Tip-Over Furniture Can Kill Kids 2
... WASHINGTON and DUBLIN , March ... Ireland -based, physician-led global certification company, today announced that ... Mark on its new LuV300 vacuum with Kompressor® technology. ... range of products from worldwide manufacturers to determine their ...
... ... , ... ... On Thursday, March 18 , lawyers from the U.S. Department of Justice will appear in Federal District ...
... Care to Pay for It Makes Little Sense , ... ... PRINCETON, N.J. , March 16 Statement ... , , ...
... and suffering caused by antibiotic-resistant bacterial infections continue to rise ... (IDSA) is urging a global commitment to develop 10 new ... to address this public health crisis and safeguard patients, health. ... a statementpublished in the April 15 issue of Clinical ...
... has long been identified as a risk factor for cardiovascular ... researchers at the University of Rochester Medical Center found that ... risk of dying suddenly from cardiac causes. Scientists found ... underweight patients had a 76 percent increase in risk ...
... ... a new laundry detergent for U.S. consumers concerned about their budget as well as ... contains 10 ounces of macro-molecule laundry detergent which cleans for up to 12 months ... over 200 washes. , ...
Cached Medicine News:Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 2Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 3Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 4Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 5Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 2Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 3Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 4Health News:NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows 2Health News:ID physicians call for 10 new antibiotics by 2020 2Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 2Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 3
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... benchtop fume hood ventilates and ... indoor release of exhaust. Bonded ... contaminants. Configurations are available with ... include final HEPA filter, work ...
... proof polypropylene exhaust hoods are designed to ... and draw a stream of air across ... the operator. Other sizes and types of ... double-slot are available on special order in ...
... Benchtop Fume Hood is an economical unit ... which a number of fume hoods are ... colleges and universities. Features include a one-piece ... rounded inside corners for easy cleaning. A ...
Medicine Products: